What is the treatment for mumps?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Mumps

Treatment for mumps is primarily supportive care as there is no specific antiviral therapy available. 1, 2

Clinical Presentation and Diagnosis

  • Mumps presents with bilateral or unilateral parotitis (swelling of the parotid glands) in 30-40% of infections, occurring approximately 16-18 days after exposure 3, 4
  • Parotitis may be preceded by prodromal symptoms including fever, headache, malaise, myalgia, and anorexia 3, 5
  • 15-20% of infections are asymptomatic, while up to 50% present with nonspecific or primarily respiratory symptoms 3, 4
  • Diagnosis is confirmed through clinical presentation plus laboratory confirmation via isolation of mumps virus, significant rise in serum mumps IgG antibody, or positive serologic test for mumps IgM antibody 1

Treatment Approach

Supportive Care

  • Provide adequate hydration to prevent dehydration 1, 5
  • Administer analgesics such as acetaminophen or NSAIDs for pain relief and fever reduction 1, 5
  • Apply warm or cold compresses to the swollen parotid glands to relieve discomfort 5
  • Recommend soft, bland foods and adequate fluid intake to minimize pain with chewing 5
  • Avoid acidic foods or beverages that may stimulate saliva production and worsen pain 5

Management of Complications

Orchitis (inflammation of testes)

  • Occurs in up to 38% of postpubertal males with mumps 3, 5
  • Treatment includes bed rest, scrotal support, local cooling, and analgesics 6
  • In severe cases, interferon alpha-2b may be considered specifically for mumps epididymo-orchitis 7

Aseptic Meningitis and Encephalitis

  • Affects 4-6% of persons with clinical cases of mumps 3
  • Management includes supportive care, pain control, and monitoring for neurological complications 4

Facial Nerve Palsy

  • If facial weakness occurs, corticosteroid therapy may be initiated (prednisone 1-2 mg/kg/day for 5-7 days followed by a taper) 1
  • Provide eye protection if facial weakness prevents complete eye closure 1

Infection Control Measures

  • Isolate infected individuals for 5 days after the onset of parotitis to prevent spread 1, 5
  • Implement droplet precautions in healthcare settings 1
  • Identify and vaccinate susceptible contacts to limit spread during outbreaks 1

Prevention

  • Vaccination with MMR (measles, mumps, rubella) vaccine is the most effective prevention strategy 3, 4
  • Two doses of MMR vaccine provide approximately 88% protection against mumps 1
  • The principal strategy to prevent mumps is to achieve and maintain high immunization levels by routinely vaccinating all children with two doses of MMR 3

Prognosis

  • Most cases of mumps resolve completely within 7-10 days without long-term sequelae 4
  • Complete recovery from complications such as facial droop occurs in approximately 70-80% of cases within 3-6 months 1
  • Serious complications are more common among adults than among children 3

References

Guideline

Treatment for Facial Droop in Mumps

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Mumps--infectious disease with various faces].

Medizinische Monatsschrift fur Pharmazeuten, 2007

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Mumps Pathophysiology and Clinical Manifestations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Parotitis: Presentation and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Mumps orchitis: report of a mini-epidemic.

The Journal of urology, 1997

Research

Mumps: a resurgent disease with protean manifestations.

The Medical journal of Australia, 2008

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.